FDA Approves FluMist Nasal Flu Vaccine for Home Use: How It Compares to the Regular Flu Shot
Getting your yearly flu vaccine is essential to prevent illness during cold and flu season. But if you’re not a fan of ...
At-home flu vaccine approved by FDA — what to know
People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...
Neurology Advisor17h
FDA Approves Self-Administration of Influenza Vaccine FluMist
The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
healthcarepackaging4d
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
News Nation on MSN4d
FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
Everyday Health3d
First-Ever Flu Vaccine for Home Use Gets FDA Approval
FluMist Home, like the original version administered in medical offices and pharmacies, is for adults under age 50 and kids 2 ...
KSBW The Central Coast6d
FDA approves first flu vaccine that can be self-administered at home
Friday’s approval from the FDA adds a second option for those ... “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving ...
ConsumerAffairs4d
FDA approves first at-home nasal spray flu vaccine for the 2-49 age range
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
The American Journal of Managed Care4d
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...